{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T19:47:11Z","timestamp":1782762431372,"version":"3.54.5"},"reference-count":52,"publisher":"Portland Press Ltd.","issue":"12","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,6,1]]},"abstract":"<jats:p>Our clinical and laboratory data suggest that levamisole should be added to the list of immunotherapeutic agents that have direct actions on podocytes and point to the usefulness of levamisole in the treatment of adult as well as paediatric patients.<\/jats:p>","DOI":"10.1042\/cs20140749","type":"journal-article","created":{"date-parts":[[2015,1,29]],"date-time":"2015-01-29T05:43:16Z","timestamp":1422510196000},"page":"883-893","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Levamisole in steroid-sensitive nephrotic syndrome: usefulness in adult patients and laboratory insights into mechanisms of action via direct action on the kidney podocyte"],"prefix":"10.1042","volume":"128","author":[{"given":"Lulu","family":"Jiang","sequence":"first","affiliation":[{"name":"Academic Renal Unit, University of Bristol, Bristol BS1 3NY, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishita","family":"Dasgupta","sequence":"additional","affiliation":[{"name":"Academic Renal Unit, University of Bristol, Bristol BS1 3NY, U.K."},{"name":"Richard Bright Renal Unit, Southmead Hospital, Bristol BS10 5B, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny\u00a0A.","family":"Hurcombe","sequence":"additional","affiliation":[{"name":"Academic Renal Unit, University of Bristol, Bristol BS1 3NY, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather\u00a0F.","family":"Colyer","sequence":"additional","affiliation":[{"name":"Academic Renal Unit, University of Bristol, Bristol BS1 3NY, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter\u00a0W.","family":"Mathieson","sequence":"additional","affiliation":[{"name":"Academic Renal Unit, University of Bristol, Bristol BS1 3NY, U.K."},{"name":"Richard Bright Renal Unit, Southmead Hospital, Bristol BS10 5B, U.K."},{"name":"President's Office, The University of Hong Kong, Pokfulam Road, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin\u00a0I.","family":"Welsh","sequence":"additional","affiliation":[{"name":"Academic Renal Unit, University of Bristol, Bristol BS1 3NY, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2015,3,27]]},"reference":[{"key":"2021113010372889800_B1","first-page":"CD001537","article-title":"Interventions for minimal change disease in adults with nephrotic syndrome","author":"Palmer","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"issue":"Suppl. 2012","key":"2021113010372889800_B2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/kisup.2012.9","article-title":"KDIGO Clinical Practice Guideline for Glomerulonephritis","volume":"2","year":"2012","journal-title":"Kidney Int. Suppl."},{"key":"2021113010372889800_B3","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s11255-012-0241-x","article-title":"Short- and long-term efficacy of levamisole in children with steroid-sensitive nephrotic syndrome","volume":"45","author":"Elmas","year":"2012","journal-title":"Int. Urol. Nephrol."},{"key":"2021113010372889800_B4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/MOP.0b013e3282f4307a","article-title":"Evaluation and management of steroid-sensitive nephrotic syndrome","volume":"20","author":"Hodson","year":"2008","journal-title":"Curr. Opin. Pediatr."},{"key":"2021113010372889800_B5","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s00467-005-1968-8","article-title":"Evidence-based management of steroid-sensitive nephrotic syndrome","volume":"20","author":"Hodson","year":"2005","journal-title":"Pediatr. Nephrol."},{"key":"2021113010372889800_B6","first-page":"CD002290","article-title":"Non-corticosteroid treatment for nephrotic syndrome in children","volume":"10","author":"Hodson","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"2021113010372889800_B7","first-page":"CD002290","article-title":"Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children","volume":"10","author":"Pravitsitthikul","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"2021113010372889800_B8","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1056\/NEJM199002083220602","article-title":"Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma","volume":"322","author":"Moertel","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"2021113010372889800_B9","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/0140-6736(91)93267-D","article-title":"Levamisole for childhood nephrotic syndrome","volume":"337","author":"Anon","year":"1991","journal-title":"Lancet"},{"key":"2021113010372889800_B10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s00467-004-1615-9","article-title":"Levamisole in steroid-sensitive nephrotic syndrome of childhood: the lost paradise?","volume":"20","author":"Davin","year":"2005","journal-title":"Pediatr. Nephrol."},{"key":"2021113010372889800_B11","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1159\/000187855","article-title":"Use of levamisole in maintaining remission in steroid-sensitive nephrotic syndrome in children","volume":"66","author":"Dayal","year":"1994","journal-title":"Nephron"},{"key":"2021113010372889800_B12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/nrneph.2011.171","article-title":"The podocyte as a target for therapies\u2013new and old","volume":"8","author":"Mathieson","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"key":"2021113010372889800_B13","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/sj.ki.5001655","article-title":"Direct effects of dexamethasone on human podocytes","volume":"70","author":"Xing","year":"2006","journal-title":"Kidney Int."},{"key":"2021113010372889800_B14","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nm.1857","article-title":"The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A","volume":"14","author":"Faul","year":"2008","journal-title":"Nat. Med."},{"key":"2021113010372889800_B15","doi-asserted-by":"publisher","first-page":"85ra46","DOI":"10.1126\/scitranslmed.3002231","article-title":"Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis","volume":"3","author":"Fornoni","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"2021113010372889800_B16","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrneph.2009.108","article-title":"New insights into the role of podocytes in proteinuria","volume":"5","author":"Patrakka","year":"2009","journal-title":"Nat. Rev. Nephrol."},{"key":"2021113010372889800_B17","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1179\/000349804225021370","article-title":"The safety, tolerability and pharmacokinetics of levamisole alone, levamisole plus ivermectin, and levamisole plus albendazole, and their efficacy against Onchocerca volvulus","volume":"98","author":"Awadzi","year":"2004","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"2021113010372889800_B18","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1681\/ASN.V133630","article-title":"A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression","volume":"13","author":"Saleem","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113010372889800_B19","doi-asserted-by":"publisher","first-page":"F182","DOI":"10.1152\/ajprenal.00548.2012","article-title":"Insulin directly stimulates VEGF-A production in the glomerular podocyte","volume":"305","author":"Hale","year":"2013","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"2021113010372889800_B20","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/path.4149","article-title":"Active proteases in nephrotic plasma lead to a podocin-dependent phosphorylation of VASP in podocytes via protease activated receptor-1","volume":"229","author":"Harris","year":"2013","journal-title":"J. Pathol."},{"key":"2021113010372889800_B21","doi-asserted-by":"publisher","first-page":"42714","DOI":"10.1074\/jbc.M106033200","article-title":"Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids","volume":"276","author":"Wallace","year":"2001","journal-title":"J. Biol. Chem."},{"key":"2021113010372889800_B22","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1210\/mend-2-12-1256","article-title":"Regulation of glucocorticoid receptor expression: evidence for transcriptional and posttranslational mechanisms","volume":"2","author":"Dong","year":"1988","journal-title":"Mol. Endocrinol."},{"key":"2021113010372889800_B23","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S1471-4892(03)00073-0","article-title":"Crosstalk between glucocorticoids and mitogen-activated protein kinase signalling pathways","volume":"3","author":"Clark","year":"2003","journal-title":"Curr. Opin. Pharmacol."},{"key":"2021113010372889800_B24","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1210\/me.2009-0443","article-title":"Glucocorticoid receptor activates poised FKBP51 locus through long-distance interactions","volume":"24","author":"Paakinaho","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"2021113010372889800_B25","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/ki.1975.105","article-title":"An ultrastructural study of the mechanisms of proteinuria in aminonucleoside nephrosis","volume":"8","author":"Ryan","year":"1975","journal-title":"Kidney Int."},{"key":"2021113010372889800_B26","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/ndt\/15.10.1547","article-title":"Glomerular function and morphology in puromycin aminonucleoside nephropathy in rats","volume":"15","author":"Lowenborg","year":"2000","journal-title":"Nephrol. Dial. Transplant."},{"key":"2021113010372889800_B27","first-page":"1641","article-title":"Podocytic cytoskeletal disaggregation and basement-membrane detachment in puromycin aminonucleoside nephrosis","volume":"142","author":"Whiteside","year":"1993","journal-title":"Am. J. Pathol."},{"key":"2021113010372889800_B28","first-page":"220","article-title":"Glomerular epithelial abnormalities associated with the onset of proteinuria in aminonucleoside nephrosis","volume":"126","author":"Messina","year":"1987","journal-title":"Am. J. Pathol."},{"key":"2021113010372889800_B29","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1038\/ki.1996.439","article-title":"Re-evaluation of foot process effacement in acute puromycin aminonucleoside nephrosis","volume":"50","author":"Inokuchi","year":"1996","journal-title":"Kidney Int."},{"key":"2021113010372889800_B30","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/BF00297236","article-title":"In\u00a0vitro effects of puromycin aminonucleoside on the ultrastructure of rat glomerular podocytes","volume":"260","author":"Bertram","year":"1990","journal-title":"Cell Tissue Res."},{"key":"2021113010372889800_B31","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1172\/JCI20402","article-title":"Induction of B7-1\u00a0in podocytes is associated with nephrotic syndrome","volume":"113","author":"Reiser","year":"2004","journal-title":"J. Clin. Invest."},{"key":"2021113010372889800_B32","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1681\/ASN.2007080836","article-title":"Urinary CD80 excretion increases in idiopathic minimal-change disease","volume":"20","author":"Garin","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113010372889800_B33","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/ki.2010.143","article-title":"Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis","volume":"78","author":"Garin","year":"2010","journal-title":"Kidney Int."},{"key":"2021113010372889800_B34","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/ndt\/gfr271","article-title":"Toll-like receptor 3 ligands induce CD80 expression in human podocytes via an NF-kappaB-dependent pathway","volume":"27","author":"Shimada","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"2021113010372889800_B35","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/ki.1988.208","article-title":"Evidence suggesting a role for hydroxyl radical in puromycin aminonucleoside-induced proteinuria","volume":"34","author":"Thakur","year":"1988","journal-title":"Kidney Int."},{"key":"2021113010372889800_B36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1136\/adc.82.1.76","article-title":"Indirect quantification of lipid peroxidation in steroid responsive nephrotic syndrome","volume":"82","author":"Kinra","year":"2000","journal-title":"Arch. Dis. Child."},{"key":"2021113010372889800_B37","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/ki.1986.24","article-title":"A role for oxygen free radicals in aminonucleoside nephrosis","volume":"29","author":"Diamond","year":"1986","journal-title":"Kidney Int."},{"key":"2021113010372889800_B38","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/S0272-6386(00)70056-4","article-title":"Protection of alpha(3) integrin-mediated podocyte shape by superoxide dismutase in the puromycin aminonucleoside nephrosis rat","volume":"35","author":"Kojima","year":"2000","journal-title":"Am. J. Kidney Dis."},{"key":"2021113010372889800_B39","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1159\/000187523","article-title":"Amelioration of antioxidant enzyme suppression and proteinuria in cyclosporin-treated puromycin nephrosis","volume":"65","author":"Wang","year":"1993","journal-title":"Nephron"},{"key":"2021113010372889800_B40","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/ki.1991.213","article-title":"Glucocorticoid activates glomerular antioxidant enzymes and protects glomeruli from oxidant injuries","volume":"40","author":"Kawamura","year":"1991","journal-title":"Kidney Int."},{"key":"2021113010372889800_B41","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1089\/ars.2006.8.1597","article-title":"NADPH oxidases in the kidney","volume":"8","author":"Gill","year":"2006","journal-title":"Antioxid. Redox Signal."},{"key":"2021113010372889800_B42","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1681\/ASN.2005020142","article-title":"Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and Bcl-2-related family proteins","volume":"16","author":"Wada","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113010372889800_B43","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1159\/000131892","article-title":"Dexamethasone's prosurvival benefits in podocytes require extracellular signal-regulated kinase phosphorylation","volume":"109","author":"Wada","year":"2008","journal-title":"Nephron Exp. Nephrol."},{"key":"2021113010372889800_B44","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/sj.ki.5002691","article-title":"Nephrin mediates actin reorganization via phosphoinositide 3-kinase in podocytes","volume":"73","author":"Zhu","year":"2008","journal-title":"Kidney Int."},{"key":"2021113010372889800_B45","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1093\/ndt\/gfr240","article-title":"Protective effects of PPAR\u03b3 agonist in acute nephrotic syndrome","volume":"27","author":"Zuo","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"2021113010372889800_B46","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1210\/jcem-59-1-25","article-title":"The new steroid analog RU 486 inhibits glucocorticoid action in man","volume":"59","author":"Bertagna","year":"1984","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2021113010372889800_B47","doi-asserted-by":"publisher","first-page":"vi26","DOI":"10.1093\/ndt\/gfg1066","article-title":"Immune dysregulation in minimal change nephropathy","volume":"18","author":"Mathieson","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"2021113010372889800_B48","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1046\/j.1365-2567.2000.00042.x","article-title":"Levamisole induces interleukin-18 and shifts type\u00a01\/type 2 cytokine balance","volume":"100","author":"Szeto","year":"2000","journal-title":"Immunology"},{"key":"2021113010372889800_B49","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1111\/j.1523-1755.2005.00723.x","article-title":"Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization","volume":"68","author":"Ransom","year":"2005","journal-title":"Kidney Int."},{"key":"2021113010372889800_B50","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1111\/j.1523-1755.2005.00205.x","article-title":"Differential proteomic analysis of proteins induced by glucocorticoids in cultured murine podocytes","volume":"67","author":"Ransom","year":"2005","journal-title":"Kidney Int."},{"key":"2021113010372889800_B51","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/j.1440-1797.2012.01645.x","article-title":"alpha-Actinin-4 is involved in the process by which dexamethasone protects actin cytoskeleton stabilization from adriamycin-induced podocyte injury","volume":"17","author":"Liu","year":"2012","journal-title":"Nephrology"},{"key":"2021113010372889800_B52","doi-asserted-by":"publisher","first-page":"F845","DOI":"10.1152\/ajprenal.00161.2010","article-title":"Dose- and time-dependent glucocorticoid receptor signaling in podocytes","volume":"299","author":"Guess","year":"2010","journal-title":"Am. J. Physiol. Renal Physiol."}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/128\/12\/883\/447138\/cs1280883.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/128\/12\/883\/447138\/cs1280883.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T06:28:45Z","timestamp":1638253725000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/128\/12\/883\/71248\/Levamisole-in-steroid-sensitive-nephrotic-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,27]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,6,1]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20140749","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725331221.793528028","asserted-by":"object"}]},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,27]]}}}